BNTX, CVAC, ARCT: Higher-Risk Stocks with Potentially Bright Futures
To be 100% clear, the above biotech stocks involve substantial risks. While not completely aspirational, these underlying companies feature an ambition that may not pan out. At the same time, the development and ultimate approval of mRNA vaccines bode very well for the future of therapeutics. Therefore, investors who have some funds earmarked for speculation may want to consider the above market ideas.